PlainBillCongress, translated.Legislation. Context. Public interest.Read twice and referred, under authority of the order of the Senate of Jan. 18, 2006, to the Committee on Finance. (text of measure as introduced: CR 1/24/2006 S25-27)
Congressional Research Service
Version 00 · Introduced in Senate · Jan 20, 2006
Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act of 2006 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) with respect to transition requirements.
Authorizes a pharmacy to fill prescriptions on a renewable 30-day basis for full-benefit dual eligible individuals during 2006 when a reasonable search by the pharmacy to locate or verify an individual's enrollment fails.
Requires the Secretary of Health and Human Services and a prescription drug plan or a Medicare Advantage-Prescription Drug (MA-PD) plan under Medicare part C (Medicare+Choice) to identify clearly all full-benefit dual eligible individuals in their data records.
Showing the opening paragraphs of the official summary.
Amends SSA title XIX (Medicaid) to prohibit conditioning Medicaid eligibility for individuals enrolled in certain creditable prescription drug coverage on enrollment in the Medicare part D drug program.
Requires the Secretary to establish process to ensure that full-benefit dual eligible individuals are not overcharged.
Requires reimbursement to states for 2006 transition costs.
Directs the Secretary to provide for outreach and education to every pharmacy participating in the Medicaid program, on the needs of full-benefit dual eligible individuals and the transition from Medicaid prescription drug coverage to part D coverage.
Directs the Secretary to ensure that an employee of the Centers for Medicare and Medicaid Services is stationed at each state health insurance counseling program to assist Medicare beneficiaries and counselors regarding the new Medicare prescription drug benefit.
Authorizes state coverage of non-formulary prescription drugs for full-benefit dual eligible individuals during 2006.
Prohibits the Secretary from terminating coverage of a full-benefit dual eligible individual unless such individual has functioning access to a prescription drug plan under part D or an MA-PD plan.
People & committees
Sen. Rockefeller, John D., IV [D-WV] · D–WV
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Read twice and referred, under authority of the order of the Senate of Jan. 18, 2006, to the Committee on Finance. (text of measure as introduced: CR 1/24/2006 S25-27)
Introduced in Senate
Primary sources
Text links open the official source. We currently store references to these documents.
Source last updated: Dec 5, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze S.2183 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine S.2183 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine S.2183 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine S.2183 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.